[1] Yin W, Luo S, Xiao Z, et al.Latent autoimmune diabetes in adults: a focus on β-cell protection and therapy[J]. Front Endocrinol (Lausanne),2022,13: 959011.
[2] 童越,肖扬,罗说明,等. 糖尿病的连续疾病谱学说[J]. 中国实用内科杂志,2020,40(1):1-4.
[3] Qiu J, Xiao Z, Zhang Z, et al.Latent autoimmune diabetes in adults in China[J]. Front Immunol, 2022, 13: 977413.
[4] 中国医师协会内分泌代谢科医师分会,国家代谢性疾病临床医学研究中心. 成人隐匿性自身免疫糖尿病诊疗中国专家共识(2021版)[J]. 中华医学杂志,2021,101(38):3077-3091.
[5] Lampasona V, Petrone A, Tiberti C, et al.Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterization of adult-onset autoimmune diabetes: non insulin requiring antoimmune diabetes(NIRAD) 4[J]. Diabetes Care, 2010, 33(1): 104-108.
[6] Buzzetti R, Tuomi T, Mauricio D, et al.Management of latent autoimmune diabetes in adults: a consensus statement from an international expert panel[J]. Diabetes, 2020, 69(10): 2037-2047.
[7] 王洋,鲁丽,刘芳薇. 起始应用胰岛素治疗对成人隐匿性自身免疫性糖尿病患者胰岛素β细胞功能的影响[J]. 中国现代药物应用,2018,12(18):116-118.
[8] Li Xia, Chen Yan, Xie Yuting, et al. Decline pattern of beta-cell function in adult-onset autoimmune diabetes: an 8-year prospective study[J]. The Journal of Clinical Endocrinology and Metabolism, 2020, 105(7): dgaa205.
[9] Buzzetti R, Tuomi T, Mauricio D, et al.Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel[J]. Diabetes, 2020, 69(10): 2037-2047.
[10] Peters KE, Chubb SAP, Bruce DG, et al.Prevalence and incidence of thyroid dysfunction in type 1 diabetes, type 2 diabetes and latent autoimmune diabetes of adults: The Fremantle Diabetes Study Phase II[J]. Clin Endocrinol (Oxf), 2020, 92(4): 373-382.
[11] Turner R, Stratton I, Horton V, et al.UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK prospective diabetes study group[J]. Lancet, 1997, 350(9087): 1288-1293.
[12] Carlsson S.Environmental(lifestyle) risk factors for LADA[J]. Curr Diabetes Rev, 2019, 15(3): 178-187. |
